These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28834593)

  • 1. Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.
    Kelm RJ; Lamba GS; Levis JE; Holmes CE
    J Cell Biochem; 2018 Feb; 119(2):2073-2083. PubMed ID: 28834593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional analysis of single-nucleotide polymorphic variants of purine-rich element-binding protein B.
    Ferris LA; Kelm RJ
    J Cell Biochem; 2019 Apr; 120(4):5835-5851. PubMed ID: 30387171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure.
    Gupta M; Sueblinvong V; Raman J; Jeevanandam V; Gupta MP
    J Biol Chem; 2003 Nov; 278(45):44935-48. PubMed ID: 12933792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic Residues Dictate the Transcriptional Repressor and Single-Stranded DNA Binding Activities of Purine-Rich Element Binding Protein B.
    Foote AT; Kelm RJ
    Biochemistry; 2023 Sep; 62(17):2597-2610. PubMed ID: 37556352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/function analysis of mouse Purbeta, a single-stranded DNA-binding repressor of vascular smooth muscle alpha-actin gene transcription.
    Kelm RJ; Wang SX; Polikandriotis JA; Strauch AR
    J Biol Chem; 2003 Oct; 278(40):38749-57. PubMed ID: 12874279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puralpha and Purbeta collaborate with Sp3 to negatively regulate beta-myosin heavy chain gene expression during skeletal muscle inactivity.
    Ji J; Tsika GL; Rindt H; Schreiber KL; McCarthy JJ; Kelm RJ; Tsika R
    Mol Cell Biol; 2007 Feb; 27(4):1531-43. PubMed ID: 17145772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic and Hydrophobic Interactions Mediate Single-Stranded DNA Recognition and Acta2 Repression by Purine-Rich Element-Binding Protein B.
    Rumora AE; Ferris LA; Wheeler TR; Kelm RJ
    Biochemistry; 2016 May; 55(19):2794-805. PubMed ID: 27064749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of growth factor independence 1 expression in patients with
    Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Allahbakhshian A; Farsani MA
    J Cancer Res Ther; 2020; 16(1):23-27. PubMed ID: 32362605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
    Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
    Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-650 exerts anti-leukemia activity by inhibiting cell proliferation through Gfi1 targeting.
    Yuan C; Xu L; Du P; Pang J
    Tumori; 2018 Oct; 104(5):369-374. PubMed ID: 28574132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of multisite single-stranded DNA recognition and ACTA2 repression by purine-rich element binding protein B (Purβ).
    Rumora AE; Wang SX; Ferris LA; Everse SJ; Kelm RJ
    Biochemistry; 2013 Jul; 52(26):4439-50. PubMed ID: 23724822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
    Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
    Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.